Sino Biopharmaceutical Ltd

SMZ1

Company Profile

  • Business description

    Listed on the Hong Kong Stock Exchange in 2000, Sino Biopharmaceutical is one of the largest Chinese drugmakers. It has four main segments: oncology, liver, surgery/analgesics, and autoimmune/respiratory. Since 2018, Sino Biopharm has been actively pivoting into an innovative drugmaker for oncology after the Chinese government launched its volume-based procurement policy for the healthcare industry, whereby it reduces the price of its generic drugs in exchange for bulk procurement of its products. Oncology drugs make up its core innovative portfolio, while the other drugs are considered generic, which currently make up about half of its total revenue. Sino Biopharm competes with Hutchmed and Hengrui in the domestic oncology market, while it has a minimal presence in the global market.

  • Contact

    1 Harbour Road
    Unit 09, 41st Floor, Office Tower, Room 4109
    Convention Plaza
    Wanchai
    Hong Kong
    HKG

    T: +852 28029886

    https://www.sbpgroup.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    22,838

Stocks News & Analysis

stocks

This defensive ASX listed REIT offers a 5% yield

Solid outlook underpinned by rent uplifts and development pipeline.
stocks

Chart of the Week: Anthropic’s IPO range sits below our fair value

Our fair value is above the IPO range, but outcomes could differ widely.
stocks

Taking a look at opportunities in gaming shares as the highly anticipated GTA 6 is released

Several gaming shares are trading at a discount to our fair value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,836.6095.80-1.07%
CAC 408,080.7466.09-0.81%
DAX 4025,463.81272.43-1.06%
Dow JONES (US)49,097.061,101.11-2.19%
FTSE 10010,452.6898.49-0.93%
HKSE22,841.62453.13-1.95%
NASDAQ23,879.20550.69-2.25%
Nikkei 22559,444.21419.930.71%
NZX 50 Index14,179.3967.86-0.48%
S&P 5007,175.83147.80-2.02%
S&P/ASX 2008,730.4091.40-1.04%
SSE Composite Index3,577.6210.21-0.28%

Market Movers